RGDS peptide

Research use only, not for human use.

RGDS peptide (Arg-Gly-Asp-Ser) is a integrin binding sequence that inhibits integrin receptor function, a tetrapeptide analogue of the cell attachment site of fibronectin.

RGDS peptide (Arg-Gly-Asp-Ser) is a integrin binding sequence that inhibits integrin receptor function, a tetrapeptide analogue of the cell attachment site of fibronectin; decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9; inhibits thrombin-induced binding of platelets to fibronectin, fibrinogen α, and von Willebrand factor with IC50 of 10 uM.

——

——

Arg-Gly-Asp-Ser

Cell Cycle/DNA Damage

Integrin

Integrin

Cancer

——

91037-65-9

433.417

C15H27N7O8

>98% (HPLC)

DMSO: ≥ 55 mg/mL

C(CC(C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)N)CN=C(N)N

L-Serine, L-arginylglycyl-L-α-aspartyl-

(-20℃)

With Ice Pack

≥ 2 years